Weight Loss 2026: GLP-1, Nutrition, Exercise, and Supplements – What the Studies Really Show
Between Wegovy, new oral GLP-1 agents, calorie deficits, and "fat burner" promises: an evidence-based look at weight, muscle mass, hydration, and meaningful supplements.
Briefly explained (TL;DR)
Weight loss through modern GLP-1-based medications is real and clinically relevant. Available evidence contradicts a simple "medication bad, discipline good" narrative. The WHO classifies GLP-1 therapies as a potential long-term treatment for adults with obesity – expressly when combined with healthy nutrition, exercise, and professional support. At the same time, these preparations are not a lifestyle shortcut for everyone and should not be obtained outside of medical indications.
The strongest non-pharmacological foundation remains a long-term sustainable diet with a calorie deficit, sufficient protein, and regular exercise. Strength training is particularly relevant during weight loss because it can reduce the loss of lean mass and improve fat loss.
Dietary supplements are not a substitute for a calorie deficit and not a "fat-burning secret." A targeted strategy makes more sense: creatine can support the maintenance or building of lean mass when combined with strength training; magnesium, vitamin D, or omega-3 can be useful, especially when diet, lifestyle, or a diagnosed deficiency justify supplementation. What is decisive is the function – not the promise on the label.
In 2026, weight loss is no longer just a question of "willpower"
Hardly any health topic has changed as much in recent years as the discussion surrounding obesity and weight loss. For a long time, the equation was reduced to "eat less, move more." Biologically, a calorie deficit is indeed the prerequisite for a permanent reduction of body energy – but the question of how people achieve this deficit, how long they can maintain it, and what body mass they lose in the process is significantly more complex.
Parallel to traditional nutritional medicine, a new pharmacological era has begun. GLP-1-based medications influence hunger, satiety, gastric emptying, and glucose metabolism. In large randomized studies, semaglutide showed significantly greater weight loss than a placebo; newer substances and combinations are expanding the therapeutic spectrum. The WHO now expressly describes obesity as a chronic, relapse-prone disease and sees GLP-1 therapies as a potential pillar of comprehensive long-term treatment for adults with obesity.
The current discussion is therefore no longer useful if framed as "pills vs. lifestyle." The better question is: What does each intervention actually do – and what remains if we consider weight not just on the scale, but also in terms of fat mass, muscle mass, performance, nutritional security, and long-term feasibility?
→ Source: WHO, Global Guideline on the use of GLP-1 medicines in treating obesity · WHO, Questions and answers on GLP-1 therapies
What does weight loss actually mean?
A decreasing body weight is not automatically synonymous with an optimal metabolic or health outcome. Water, glycogen, intestinal contents, fat mass, and lean mass all fluctuate on the scale. Especially during a calorie-restricted diet, muscle tissue can be lost alongside fat. Therefore, the composition of the weight loss is decisive.
This explains an important difference between "losing weight" and "reducing body fat while maintaining as much functional mass as possible." Two people can both lose ten kilograms and still achieve completely different results. Someone who also does strength training and follows a sufficiently protein-rich diet can influence their body composition more favorably than someone who exclusively reduces energy intake drastically.
A 2025 meta-analysis on resistance training during a diet for people with overweight or obesity arrived at a particularly relevant conclusion: strength training did not change total weight significantly compared to a diet without strength training, but it significantly protected against the loss of lean mass, increased fat loss, and improved muscle strength. This is precisely a point often missing in viral "before-and-after" images.
→ Source: Binmahfoz et al. (2025), Systematic Review and Meta-Analysis on strength training during weight loss
Round 1: Hydration – important, but no magical fat burner
Moderator: Let's start with one of the most common promises in the weight loss world: water. The reference material presents hydration as a fundamental prerequisite for metabolism and weight regulation. The basic idea is sound – the body needs water for normal physiological processes. The more scientifically accurate wording, however, is: Sufficient fluid intake supports normal bodily functions; it does not replace a calorie deficit and does not simply "switch on" fat burning.
For adults, the EFSA uses "Adequate Intake" values for total water intake, i.e., water from beverages and food. Under moderate conditions, these are approximately 2.0 liters per day for women and 2.5 liters for men. Individual needs change with physical activity, heat, illness, or heavy sweating. In an everyday diet, some of the water also comes from food – which is why a rigid drinking target for every person is not practical.
For people in a weight reduction phase, the practical question is more important than a magic number: Drink regularly, orient yourself by thirst and daily routine, increase intake during sweat loss, and avoid answering thirst with calorie-rich drinks. Water, unsweetened tea, and low-calorie beverages can help to keep your energy balance on track.
Hydration becomes particularly interesting in combination with training. Those who sweat heavily can lose not only water but also electrolytes. At the same time, the idea that "the more water, the better" is wrong. Extreme consumption in a short time can be dangerous. The art is not in maximal fluid, but in sufficient and situationally adapted fluid intake.
→ Sources: EFSA, Dietary Reference Values · EFSA, Practical nutrition recommendations
Important during weight loss
Short-term weight loss after reducing carbohydrates or increasing fluid intake can partly result from changes in glycogen and water levels. This is normal and does not automatically mean that an equal amount of body fat has been lost. For long-term assessment, weight trends, waist circumference, performance, and – if available – body composition are more meaningful than individual daily values.
Round 2: GLP-1 medications – what is real effect and what is marketing?
Moderator: GLP-1-based medications have fundamentally changed weight medicine. However, it is important not to lump all preparations together. Semaglutide and other established medicines are approved therapies with large clinical studies. Other molecules are still in development and cannot be equated with an approved product.
The WHO recommends GLP-1 therapies for adults with obesity as a potential long-term treatment – however, conditionally and as part of comprehensive care. The WHO explicitly names liraglutide, semaglutide, and tirzepatide in its guideline. At the same time, it warns against non-regulated or counterfeit products obtained through informal or online channels.
The mechanism of action is more than just "less hunger." GLP-1-based medications influence glucose regulation, promote insulin secretion when blood sugar is elevated, reduce glucagon, and slow down gastric emptying. The result can be a stronger and longer-lasting feeling of satiety. As a result, spontaneous energy intake drops for many people.
The decisive point for consumers: The clinical benefit of the medications is real, but the context of their application is just as real. Treating obesity involves different goals than wanting to lose a few kilograms quickly for a vacation. The indication, comorbidities, contraindications, side effects, nutrition, muscle mass, and the long-term strategy therefore belong together.
→ Sources: WHO, 2025 GLP-1 Guideline · WHO, Safety statement on GLP-1, 30.07.2026
Semaglutide: large studies, large effects – and still no "miracle cure"
In the well-known STEP-1 study, 1,961 adults with overweight or obesity without diabetes were studied in a randomized trial for 68 weeks. Semaglutide 2.4 mg plus lifestyle intervention led to a mean weight change of approximately −14.9 %, compared to −2.4 % with placebo plus lifestyle intervention. Such results are clinically relevant and explain why GLP-1 therapies have changed obesity medicine so significantly.
At the same time, study endpoints should not be confused with individual promises. An average does not mean that every person loses 15 %. Furthermore, the environment of the studies is important: medical support, regular check-ups, and structured lifestyle measures are part of the overall intervention.
Another important realization is the role of treatment over longer periods. Weight regulation is biologically not static. When body weight drops, hunger, energy expenditure, and other regulatory mechanisms change. Therefore, the question "How fast does it work?" may be less relevant than "What does a long-term, safe strategy look like?"
→ Source: Wilding et al., NEJM – Once-Weekly Semaglutide in Adults with Overweight or Obesity
Aleniglipron: The reference was early – in 2026, there are now published Phase 2b data
The reference material describes aleniglipron as a novel oral GLP-1 option and mentions specific figures. These data can now be better contextualized: A Phase 2b study published in 2026 describes aleniglipron as an orally administered small-molecule GLP-1 receptor agonist currently in development.
In the ACCESS study program, 230 adults with overweight or obesity and an average BMI of 39.5 kg/m² were randomized. The daily dose was increased over four weeks to 45, 90, or 120 mg. After 36 weeks, the placebo-adjusted mean change in body weight was −8.2 %, −9.8 %, and −11.3 % for the three dose groups.
The study also reports that gastrointestinal side effects – particularly nausea and vomiting – were predominantly mild to moderate and decreased over time. Treatment discontinuations due to treatment were 10.4 % across the aleniglipron arms. The molecule, however, remains an investigational product and therefore cannot be portrayed like an established, approved medicine.
This is precisely where it becomes clear why three different questions must be separated for new active ingredients: Does it work? – in this study, yes, with a clear dose-response relationship. Is it approved? – that is a regulatory question. What does the long-term profile look like? – that requires further data.
→ Source: ACCESS Phase 2b, Aleniglipron, PubMed 2026
| Approach | What it primarily changes | Evidence / Scale | What it doesn't automatically solve |
|---|---|---|---|
| GLP-1 / GIP medications | Appetite, satiety, glucose regulation, gastric emptying | Large RCTs show clinically relevant weight loss; semaglutide approx. −14.9 % in STEP 1 after 68 weeks | No automatic guarantee for sufficient protein intake, strength training, nutritional quality, or long-term behavioral change |
| Calorie deficit | Overall energy balance | Physiological prerequisite for net loss of stored body energy | Alone, says nothing about muscle maintenance, micronutrient supply, or suitability for daily life |
| High-protein diet | Satiety and provision of amino acids | Meta-analysis: higher protein intake can better maintain lean mass during weight loss | No substitute for calorie deficit or training |
| Strength training | Mechanical stress, strength, and muscle maintenance | 2025 meta-analysis: less loss of lean mass and more fat loss during a diet | Does not automatically create an energy deficit on its own |
| Supplements | Depending on the substance, e.g., creatine stores, micronutrient intake, or certain physiological functions | Mostly small or uncertain effects for classic "fat burners"; evidence is stronger for creatine in connection with strength training | No supplement replaces a sustainable diet or medical therapy |
Summary: Successful weight loss is rarely the result of a single tool. Medications can influence energy intake; nutrition and exercise significantly determine the quality of weight loss; supplements are supplementary tools, not an independent strategy.
Round 3: The "Metabolic First Principles" – where the reference is correct and where it should be phrased more cautiously
The reference template argues that one should not simply "switch off" hunger chemically, but rather consider the upstream factors of nutrition, insulin, exercise, and metabolic health. This direction is sensible. Less sound, however, is the idea that chronically elevated insulin levels are the sole or primary cause of all obesity.
The human energy balance is a network of hunger, satiety, energy expenditure, sleep, physical activity, stress, medication, genetics, environment, and food availability. Insulin is a central regulator of nutrient metabolism, but the statement "insulin high = fat burning off" does not imply that every instance of weight loss can be explained solely by insulin reduction. People can lose weight using different forms of diet as long as a negative energy balance is maintained over a longer period.
This also explains why focusing on ultra-processed foods can be practically useful without turning it into a universal metabolic theory. Energy density, protein, fiber, eating speed, flavor, availability, and satiety change how easy or difficult it is to maintain a deficit in everyday life.
Intermittent fasting can be a helpful structural model for some people because it reduces the number of eating opportunities. However, it is not automatically superior to classic calorie reduction. Anyone who develops cravings later due to fasting or who can no longer sensibly incorporate training and protein intake has not gained any metabolic improvement from it.
The same applies to keto. A ketogenic diet can reduce weight and be useful for specific medical indications. However, the presence of ketone bodies is not automatically proof that every person in ketosis loses fat faster or more sustainably than with other well-planned forms of nutrition.
→ Classification of supplement and weight management evidence: NIH Office of Dietary Supplements – Dietary Supplements for Weight Loss
Protein: The underestimated part of a successful weight loss strategy
When people lose weight, they generally want to reduce fat mass primarily – not muscle. Protein is therefore of interest not as a "fat burner," but as a building material and satiety factor. A systematic review and meta-analysis from 2024 examined which protein intake can promote the maintenance of muscle mass during weight loss. The authors report that higher protein intake can be more favorable for lean body mass than no increase, and that an intake below 1.0 g/kg/day was associated with a higher risk of muscle mass decline, while higher amounts may be more advantageous.
This is not a call to define exactly the same number of grams for every person across the board. Body weight, age, kidney function, activity level, baseline diet, and training status all play a role. Especially in cases of severe obesity, calculating based on actual body weight can lead to unrealistically high values. Individual nutritional counseling is useful here.
In practice, however, the protein point can be summarized simply: A calorie-reduced diet should not be planned "only with less," but also with sufficient nutrients. A high-protein meal with vegetables, legumes, fish, eggs, dairy products, or suitable plant-based protein sources is something different in the long term than a drastically reduced diet plan consisting mainly of coffee and small snacks.
→ Source: Systematic Review and Meta-Analysis on higher protein intake in overweight and obesity
Round 4: Which dietary supplement is actually interesting for weight loss?
Moderator: Now we come to the part where the supplement market gets loudest. "Metabolism Booster," "Fat Burner," "Appetite Control," "Thermogenesis" – the terms are powerful, the data often significantly weaker.
The NIH Office of Dietary Supplements reaches a sober conclusion regarding many typical weight loss supplements: some ingredients may show small effects, but the scale is often small or methodologically uncertain. Green tea, for example, can have a small effect, while glucomannan shows little to no reliable weight loss. With green tea extracts, there are also safety issues, especially with highly concentrated products.
For VEYT, therefore, the more sensible connection to the topic is not: "This supplement will make you slim." But rather: "Which nutrient can support a concrete pillar of your weight loss strategy?"
Creatine: not for burning fat – but for protecting the training side
Especially with a calorie-reduced diet and simultaneous strength training, creatine is an interesting candidate. Its role is not to directly "melt away" body fat. Rather, creatine supports energy supply during intensive muscle work and is well-studied when combined with resistance training.
A systematic review and meta-analysis published in 2024 on adults under 50 found an additional increase in lean body mass of approximately 1.14 kg compared to strength training alone, as well as small improvements in body fat percentage and fat mass. A larger dose-response meta-analysis published in 2025 involving 61 studies confirmed an increase in lean body mass, but clarified that creatine did not reliably lower fat mass, BMI, or overall body fat percentage.
This is exactly the kind of result that is interesting for a serious weight loss article: Creatine is not a fat burner. However, it can be a useful supplement for people who want to maintain or improve their training performance and lean body mass as well as possible during a diet.
An important side effect of interpretation: Creatine can increase body weight due to additional bound water in the muscles. Anyone looking only at the scale might therefore mistakenly believe that the weight loss "did not work." Body weight and body composition must be assessed together.
→ Sources: Desai et al. (2024), Creatine + Resistance Training Meta-Analysis · Ashtary-Larky et al. (2025), Creatine Dose-Response Meta-Analysis
Pure Creatine Performance
Creatine monohydrate in tablet form. Relevant primarily for the training component of a weight loss strategy – not as a "fat burner," but to support physical performance during intensive training.
View Pure Creatine Performance →Magnesium: useful for nutrient intake – but not as a weight loss drug
Magnesium appears in almost every "metabolism" discussion. The reason is understandable: Magnesium contributes to normal muscle function and normal energy metabolism. However, it cannot be deduced from this that additional magnesium intake will automatically reduce body fat faster.
Especially for people who train, sweat profusely, or change their diet significantly during a diet, sufficient micronutrient intake is important. In the case of a real deficiency, correction can be physiologically relevant. If the supply is already sufficient, however, "more" is not automatically "better."
Another practical point: A very low-calorie diet can lead to a lower intake of nutrient-dense foods overall. Therefore, the question regarding magnesium should not be "Which magnesium burns fat?" but rather "Is my intake adequate – and is there a concrete reason for supplementation?"
According to product information, the VeyT Multi-Magnesium Bio-Complex combines magnesium bisglycinate, citrate, malate, and taurate, providing 200 mg of magnesium per daily dose. For the blog, the connection to the topic is therefore: Magnesium as part of a sufficient nutrient intake during an active weight loss phase, not as a direct weight loss formula.
→ Source for product declaration: VeyT Multi-Magnesium Bio-Complex
Multi-Magnesium Bio-Complex
200 mg of magnesium per daily dose from four forms. An option for people who want to supplement their micronutrient intake around training and daily life, if supplementation is individually useful.
View Multi-Magnesium Bio-Complex →Vitamin D: Interesting for weight loss if levels are insufficient
Vitamin D is also frequently marketed as a "metabolism vitamin." The more serious assessment is simpler: Vitamin D is an essential micronutrient with important physiological functions; a deficiency should be avoided or treated. However, it does not follow from this that vitamin D supplements produce significant additional fat loss in people with normal levels.
The topic can become particularly relevant if someone consumes few vitamin D-rich foods during a long diet, spends little time outdoors, or is already prone to low levels. In such situations, an individual assessment can be useful. The goal is then to optimize nutrient intake – not "Vitamin D as a fat burner."
With Lumina D3 K2, VeyT offers a product with vitamin D3 and K2 (MK-7). In the article, it should therefore be placed as a nutritional topic, not as a direct weight loss aid. Precisely this distinction increases the credibility of the entire contribution.
→ Source for product declaration: VeyT Lumina D3 K2
Lumina D3 K2
Vitamin D3 + K2 (MK-7) in drops. In the context of weight loss, relevant primarily when individual levels justify supplementation.
View Lumina D3 K2 →Omega-3: not a "fat burner," but a sensible nutritional issue
Omega-3 fatty acids are frequently associated with the heart, brain, and inflammatory processes. In a weight loss article, however, it should not be claimed that omega-3 automatically makes body fat disappear. The better connection is: Anyone improving their dietary quality should also pay attention to fat quality and the intake of long-chain omega-3 fatty acids.
The EFSA cites 250 mg of long-chain omega-3 fatty acids per day as an amount that can contribute to normal heart function in adults. This is a statement about nutrient effects and not an approval as a weight reduction aid.
According to product information, VeyT Omega-3 Gold provides 600 mg of omega-3 fatty acids per daily dose, of which 360 mg are EPA and 240 mg are DHA. If a person eats little fatty fish and supplementation fits individually, such a product can be part of a comprehensive dietary routine. Here, too: Nutrient intake is not the same as fat burning.
→ Sources: EFSA, Omega-3 and Nutrition · VeyT Omega-3 Gold
+
DHA
Pure Omega-3 Gold
600 mg of omega-3 per daily dose, of which 360 mg EPA and 240 mg DHA according to product information. Relevant as part of a balanced dietary strategy – not as an independent weight loss product.
View Omega-3 Gold →What about classic "fat burners"?
This is where it becomes especially important to distinguish between marketing and evidence. The NIH summarizes numerous ingredients advertised in weight loss supplements: caffeine, green tea, glucomannan, bitter orange, garcinia, coffee extracts, and complex multi-ingredient mixtures. The data often show only small effects, inconsistent results, or relevant safety questions.
Green tea or green tea catechins plus caffeine can show a small additional effect on weight or energy expenditure in studies. However, the benefit is not comparable to the magnitudes of modern obesity medications. With highly concentrated green tea extracts, there are also safety concerns regarding liver problems. A beverage is therefore not the same as a high-dose extract.
Glucomannan is an interesting example: It is a soluble fiber source that binds water. However, the NIH assessment describes little to no reliable weight loss. This demonstrates a fundamental principle of the supplement market: A plausible mechanism is not yet proof of a relevant clinical effect.
→ Source: NIH ODS – Dietary Supplements for Weight Loss
Round 5: Sleep, stress, and the invisible part of the energy balance
Anyone considering only food and training for weight loss overlooks another major lever: sleep. Lack of sleep can influence hunger, eating behavior, motivation for exercise, and subjective stress levels. For an evidence-based strategy, this does not mean that "eight hours of sleep burns fat." It means that a chronically poor sleep routine can make it more difficult to adhere to a sensible nutrition and exercise strategy.
Stress also affects daily life in several ways: more snacking opportunities, emotional eating, less physical activity, poorer sleep, and higher perceived exertion. This is why stress management is not just a wellness extra, but can be a practical adherence strategy.
This also makes it clear why "discipline" alone is an insufficient explanation. Successful weight loss is often a system problem: What does your food environment look like? When do you eat? How do you sleep? How do you plan your protein? Do you work out? What happens on stressful days? Which form of nutrition can you maintain for six months or longer?
→ Supplementary context: NIH ODS, Overview of weight loss strategies
Round 6: Fasting, Low-Carb, and Keto – Tools, Not Religion
The reference template emphasizes intermittent fasting, low-insulin states, and ketosis. These concepts can be useful if they help to structure energy intake and maintain a diet over a longer period.
Intermittent fasting is therefore primarily a temporal organization of food intake. Some people manage well with it because they have fewer decisions to make. Others sleep worse, have less optimal workouts, or end up eating significantly more later. The right method is, therefore, the one that enables a sensible energy deficit, provides sufficient protein and micronutrients, and works in everyday life.
With keto, a similar mechanism comes into play: through significant carbohydrate reduction, ketone bodies can rise. This can change appetite control in some people and influence the switch in energy substrates used. However, it does not mean that carbohydrates are fundamentally "fattening" and ketosis is fundamentally "fat-burning." The decisive factor remains the total energy balance and food selection.
A good weight loss plan therefore does not have to choose the "purest" metabolic philosophy. It must be measurably effective, nutritionally adequate, and sustainably implementable.
The Muscle Question: Why the Mirror Doesn't Tell the Whole Story
A particularly important point for 2026 is body composition. The faster and more significantly weight drops, the more important the question becomes of how much of that is fat and how much is fat-free mass.
The meta-analysis on strength training during weight loss published in 2025 is clearly helpful here: the training was not necessary to move the scale downward more, but it protected fat-free mass and increased fat loss. This is physiologically and practically relevant. Muscle tissue is not just about "aesthetics," but is important for strength, mobility, and physical reserve.
This is why strength training also belongs in strategies involving GLP-1 therapy. When appetite drops significantly, it can become easier to consume too little protein or too little energy overall. The solution is not to demonize medication across the board, but to make the rest of the strategy more targeted: protein-rich meals, sufficient micronutrients, strength training, and medically supervised dosing.
→ Source: Binmahfoz et al. (2025)
Expert Perspectives & Protocol Breakdown
The Perspective of Obesity Medicine
What the current guidelines emphasize: Obesity is increasingly understood as a chronic condition for which long-term strategies may be necessary. The WHO recommends GLP-1 therapies for adults with obesity as one possible option, but not as an isolated solution. Nutrition, physical activity, and professional support remain part of the overall concept.
→ Source: WHO Global Guideline, 2025
The Perspective of Dr. Eric Berg
What his content emphasizes: Dr. Eric Berg frequently talks about nutrition, carbohydrate reduction, fasting, and insulin regulation. This perspective can be interesting as a behavioral model. However, it should be distinguished from clinical guidelines and the broader evidence. A person does not necessarily have to practice keto to lose weight, and insulin is not the sole variable of weight regulation.
→ Source: drberg.com
The Perspective of Cell and Longevity Research
The FoundMyFitness perspective shifts the focus more toward micronutrients, metabolism, mitochondrial function, and cellular adaptation. Such mechanisms are scientifically interesting, but they should not be automatically translated into a clinical weight loss effect. A biological mechanism can be plausible and yet still not produce any relevant additional weight loss in randomized trials.
→ Source: FoundMyFitness
Where They Differ
The biggest difference lies in the emphasis: metabolically oriented voices stress insulin, carbohydrates, and fasting; clinical obesity medicine emphasizes chronic disease mechanisms, evidence-based medication, and long-term care. The most sensible synthesis is neither blind trust in medication nor the notion that every condition is solvable exclusively through discipline and keto.
What the Evidence Says
The most robust common line is: Weight can be reduced through various paths, but sustainable health requires more than just a lower number on the scale. GLP-1 medications can provide strong effects when indicated. An energy deficit remains physiologically necessary. Protein and strength training help maintain fat-free mass. Supplements can complement a targeted nutritional intake, while classic fat-burners usually show only small or uncertain effects.
An Evidence-Based 6-Step Weight Loss Plan
- Define the goal: Not just "weighing as little as possible," but reducing body fat, maintaining performance, and establishing a long-term routine.
- Design a realistic energy balance: A moderate, manageable deficit is more important in the long term than aggressive short-term diets.
- Prioritize protein: Every main meal should contain a high-quality protein source; individual amounts should suit your body, training, and health status.
- Incorporate strength training: Train systematically several times a week to protect fat-free mass and strength during weight loss.
- Ensure hydration and micronutrients: Drink regularly, prefer nutrient-dense foods, and use supplements in a targeted rather than blanket manner.
- Professionally evaluate medical options: For obesity, GLP-1-based medications may be sensible. They belong in professional hands and should be combined with nutrition, physical activity, and monitoring.
VEYT Supplement Matrix for the Weight Loss Phase
| Supplement | Sensible Role | What the evidence does NOT say | VEYT Context |
|---|---|---|---|
| Creatine | Support for training performance and fat-free mass in combination with strength training | Not a direct fat burner; may increase body weight due to water in muscles | Pure Creatine Performance |
| Magnesium | Micronutrient supply, normal muscle function, and energy metabolism | No independent weight loss effect with adequate supply | Multi-Magnesium Bio-Complex |
| Vitamin D3 + K2 | Targeted supplementation in case of inadequate intake or individually determined need | No proven "fat burner" mechanism for people with sufficient vitamin D status | Lumina D3 K2 |
| Omega-3 | Nutritional quality and intake of EPA/DHA as part of a balanced diet | No substitute for a calorie deficit and no classic fat burner | Reines Omega-3 Gold |
The matrix categorizes products according to their plausible role in a weight loss strategy. It is not an individual recommendation for intake and does not replace medical or nutritional advice.
Important note regarding GLP-1 and supplements
GLP-1-based medications should only be used after medical evaluation and in accordance with approved use. The WHO explicitly warned in 2026 against the increasing use outside of medical indications as well as products from informal or unregulated sources.
In the event of severe appetite reduction, persistent vomiting, significant gastrointestinal discomfort, pre-existing conditions, pregnancy, or the concurrent use of multiple medications, medical advice should be sought. Dietary supplements do not replace a diagnosis or pharmaceutical therapy.
Frequently Asked Questions about Weight Loss, GLP-1, and Supplements
Is GLP-1 better than a diet?
The question is too broad. GLP-1-based medications can enable significantly stronger weight loss in cases of medical indication compared to lifestyle measures alone, as shown by large randomized trials. However, they do not replace adequate nutrition, physical activity, or long-term care. The WHO explicitly recommends GLP-1 within the framework of comprehensive obesity management.
Can you lose weight faster with water?
Adequate fluid intake supports normal body functions and can replace high-calorie drinks. However, water is not an independent fat burner. Higher fluid volume can change weight in the short term without a corresponding amount of body fat being lost. Individual fluid intake depends on, among other things, gender, diet, activity, temperature, and sweat loss.
Is creatine sensible for weight loss?
For active people, creatine can be sensible, especially if strength training is part of the strategy. The best evidence relates to fat-free mass and training adaptations, not direct fat burning. Furthermore, creatine can bind additional water in the musculature and thus increase body weight on the scale.
Which supplement burns the most fat?
None of the readily available dietary supplements have a weight loss effect in the same order of magnitude as modern obesity medications. Some substances such as caffeine or combinations of caffeine and green tea catechins show small effects, but according to the NIH, these are limited and cannot be equated with a medically relevant therapy.
Does magnesium help with weight loss?
Magnesium is important for normal physiological functions, but a magnesium supplement is not a direct weight-loss drug. In the case of a deficiency, correction can be sensible. Without a deficiency, there is no evidence that additional magnesium intake leads to significant weight loss on its own.
Does vitamin D help with fat loss?
Vitamin D is an important nutrient, but a normal vitamin D supply should not be confused with a "fat burner" effect. Targeted supplementation is primarily a question of supply. Anyone who suspects a deficiency should consider an individual medical assessment.
Is fasting better than counting calories?
Fasting can be a practical structure for some people because it reduces opportunities to eat. However, it is not a biological necessity for weight loss. The decisive factor is whether the chosen structure enables a reasonable energy deficit in the long term without worsening nutrition, protein supply, training, or sleep.
What is better: cardio or strength training?
Both have their place. From the perspective of body composition, strength training during a diet is particularly valuable because it can reduce the loss of fat-free mass and increase fat loss. Endurance training additionally improves cardiovascular fitness and can increase energy expenditure.
Can you take GLP-1 and use supplements at the same time?
That depends on the specific medication, the person, pre-existing conditions, and the supplements used. Anyone taking medications for diabetes, blood pressure, or other conditions, or combining multiple products, should have the entire routine reviewed by a doctor or pharmacist. "Natural" does not automatically mean free of interactions.
Why am I suddenly not losing weight despite a diet?
Weight fluctuates daily due to water, glycogen, bowel contents, salt, menstrual cycle, training, and other factors. A short-term plateau does not automatically mean that no fat is being lost. It is more sensible to look at a multi-week trend rather than comparing two single days.
When should weight loss be medically supervised?
In cases of obesity, significant weight changes, eating disorders, pregnancy, chronic illnesses, the use of multiple medications, or the use of prescription weight-loss drugs, professional support is particularly important. Unexplained weight loss without a diet should also be medically clarified.
Can you gain weight again after GLP-1 therapy?
Yes, weight gain after discontinuation is possible. This is precisely why modern obesity medicine increasingly views the condition as chronic and prone to relapse. A long-term strategy following a therapy decision should therefore be factored in from the start.
Editorial Verdict: The best weight loss strategy is not a product
The great weight loss debate can be answered with more nuance in 2026 than just a few years ago.
First: GLP-1-based medications work. Their efficacy is proven by large clinical trials, and the WHO acknowledges their potential role in the long-term treatment of obesity.
Second: It does not follow that every person needs medication. For those without a medical indication, the idea of a lifestyle pill is not a scientific shortcut.
Third: Diet and exercise are not obsolete just because there are new medications. They remain the foundation of daily energy balance and play a decisive role in determining which body mass is lost and which is maintained.
Fourth: Strength training and protein deserve more attention in every modern weight loss strategy. Anyone who only looks at the scale may mistake a visually and functionally poor weight loss for a success.
Fifth: Nutritional supplements should be chosen based on their actual function. Creatine is interesting for training and lean mass. Magnesium is relevant for general intake. Vitamin D can be useful if levels are insufficient. Omega-3 can complement the diet. However, none of these products should be sold as standalone fat burners.
Ultimately, this is the most sensible “metabolic first principles” lesson: Build the foundation first, use medications where they are medically indicated, and only use supplements where they serve a clear physiological purpose.
The VeyT 30-day protocol for an intelligent weight loss phase
Week 1 – Fundamentals
Track weight as a weekly average, waist circumference, sleep, and training. Eliminate liquid calories as much as is practical. Establish three clear, protein-rich meals or an eating structure that works for you.
Week 2 – Movement
Begin or structure strength training. Supplement with everyday movement and regular walks. The goal is not maximum exhaustion, but manageable strain.
Week 3 – Micronutrient Check
Check your diet and personal risk factors. Do not automatically supplement magnesium, vitamin D, omega-3, or other products; use them based on your actual dietary situation and individual needs.
Week 4 – System over motivation
Do not just evaluate weight. Ask: Is the waist smaller? Does strength remain stable? Are you sleeping better? Is the diet suitable for everyday life? Can you continue the routine for another eight weeks?
References & Scientific Citations
- World Health Organization (2025): WHO issues global guideline on GLP-1 medicines for obesity
- World Health Organization (2025): Obesity: GLP-1 therapies – Questions & Answers
- World Health Organization (30.07.2026): Statement on safe and appropriate use of GLP-1 receptor agonists
- Wilding, J.P.H. et al. (2021): Once-Weekly Semaglutide in Adults with Overweight or Obesity, New England Journal of Medicine
- Aleniglipron ACCESS Phase 2b (2026): Oral small-molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity
- Binmahfoz, A. et al. (2025): Effect of resistance exercise on body composition during dietary weight loss
- Protein meta-analysis (2024): Enhanced protein intake on maintaining muscle mass, strength, and physical function
- Desai, I. et al. (2024): Effect of Creatine Supplementation on Resistance Training-Based Changes to Body Composition
- Ashtary-Larky, D. et al. (2025): Creatine supplementation and resistance training: systematic review and dose-response meta-analysis
- NIH Office of Dietary Supplements: Dietary Supplements for Weight Loss – Health Professional Fact Sheet
- EFSA: Dietary Reference Values for water and omega-3 fatty acids
- VeyT: Pure Creatine Performance
- VeyT: Multi-Magnesium Bio-Complex
- VeyT: Lumina D3 K2
- VeyT: Reines Omega-3 Gold
- Dr. Eric Berg: drberg.com
- FoundMyFitness: FoundMyFitness